AventaCell BioMedical Corp.

AventaCell is among the world leaders developing novel human-derived products, human platelet lysate, for use in cell culture and tissue regeneration. The technologies used offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production.

Supplies